EXELON CORP — Director's Dealing 2020

Jan 22, 2020

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2019-12-31

Reporting Person: Khouzami Carim V (CEO of BGE)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11008	Direct
Common Stock (401k Shares)	643	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit Award 2017	$0		Common Stock (1289)	1289	Direct
Restricted Stock Unit Award 2018	$0		Common Stock (2275)	2275	Direct
Restricted Stock Unit Award 2019	$0		Common Stock (2674)	2674	Direct
Deferred Compensation Equivalent Shares	$0		Common Stock (671)	671	Direct

Footnotes

F1: Shares held as of December 31, 2019 in a multi-fund 401(k) Plan to be settled in cash upon the reporting person's termination of employment for any reason on a 1:1 basis. Shares are acquired through regular periodic contributions, company matching contributions, and the quarterly reinvestment of dividends.

F2: Previously awarded restricted stock units (RSUs) granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development committee's first meeting in January or February and vest in 1/3 increments on the date of the committee's first annual meeting in the first, second and third years after the award was granted. Award balances accrue addtional RSUs through quarterly dividend reinvestment that vest on the same schedule as the underlying award.

F3: Balance includes 10 shares acquired through quarterly dividend reinvestment during 2019 from the date that Mr. Khouzami became a reporting person.

F4: Balance includes 18 shares acquired through quarterly dividend reinvestment during 2019 from the date that Mr. Khouzami became a reporting person.

F5: Balance includes 21 shares acquired through quarterly dividend reinvestment during 2019 from the date that Mr. Khouzami became a reporting person.

F6: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition.

F7: Balance includes 32 share equivalents accrued through quarterly dividend reinvestment during 2019 from the date that Mr. Khouzami became a reporting person.